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The increasing prevalence of multi-drug–resistant (MDR) strains of Pseudomonas aeruginosa among critically ill
humans is of significant concern. In the current study, we show that MDR clinical isolates of P. aeruginosa representing
three distinct genotypes that display high virulence against intestinal epithelial cells, form novel appendage-like
structures on their cell surfaces. These appendages contain PstS, an extracellular phosphate binding protein. Using
anti-PstS antibodies, we determined that the PstS-rich appendages in MDR strains are involved in adherence to and
disruption of the integrity of cultured intestinal epithelial cell monolayers. The outer surface–expressed PstS protein
was also identified to be present in P. aeruginosa MPAO1, although to a lesser degree, and its role in conferring an
adhesive and barrier disruptive phenotype against intestinal epithelial cells was confirmed using an isogenic DPstS
mutant. Formation of the PstS rich appendages was induced during phosphate limitation and completely suppressed
in phosphate-rich media. Injection of MDR strains directly into the intestinal tract of surgically injured mice, a known
model of phosphate limitation, caused high mortality rates (60%–100%). Repletion of intestinal phosphate in this
model completely prevented mortality. Finally, significantly less outer surface PstS was observed in the MPAO1 mutant
DHxcR thus establishing a role for the alternative type II secretion system Hxc in outer surface PstS expression. Gene
expression analysis performed by RT-PCR confirmed this finding and further demonstrated abundant expression of
pstS analogous to pa5369, pstS analogous to pa0688/pa14–55410, and hxcX in MDR strains. Taken together, these
studies provide evidence that outer surface PstS expression confers a highly virulent phenotype of MDR isolates
against the intestinal epithelium that alters their adhesive and barrier disrupting properties against the intestinal
epithelium.
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Introduction
Infection due to P. aeruginosa continues to be a major cause
of mortality among critically ill and immuno-compromised
patients despite the development of newer and more power-
ful antibiotics. Both the immunoevasive nature of P.
aeruginosa as well as its acquisition of multi-drug resistance
makes elimination of this organism a particular challenge.
Multi-drug–resistant (MDR) strains of P. aeruginosa, deﬁned as
resistant to at least three of the following antibiotics:
ceftazidime, imipenem, gentamicin or ciproﬂoxacin, are
often isolated from patients exposed to prolonged intensive
care-type therapies [1]. Yet antibiotic resistance itself does
not confer enhanced virulence [2], and therefore the ability
to discriminate between virulent versus non-virulent pheno-
types among colonizing multi-drug resistant isolates would be
a major step in predicting the particular threat of a
colonizing strain of P. aeruginosa. The primary site of
colonization and a frequent source of subsequent infection
of P. aeruginosa is the gastrointestinal tract reservoir, where as
many as 50% of critically ill patients are colonized within 3
days of admission with as many as 30% of strains displaying
antibiotic resistance [3]. Yet little is known about the
behavior of these pathogens in this site, especially those that
are multi-drug resistant. We recently screened several strains
of MDR isolates from hospitalized patients and characterized
their virulence against the intestinal epithelium using an in
vitro model of cultured intestinal epithelial monolayers [2].
The majority of strains (60%) were found to be either
attenuated or have no effect in their ability to adhere to or
disrupt the integrity of the intestinal epithelium. However
several strains representing three distinct genotypes, showed
extremely high adherence capacity and a profound ability to
disrupt the barrier function of cultured intestinal epithelial
cells. These strains harbored the exoU gene, known to encode
the most toxic effector protein of the type III secretion
apparatus, thus possibly explaining their extreme toxicity
against cultured intestinal epithelial cells. However, exoU
expression is dependent on contact to host epithelial cells,
and as recently shown with the exoU positive strain P.
aeruginosa PA103 [4], lack of adherence leads to a loss of
cytotoxicity against cultured epithelial cells [5] despite an
intact exoU gene. Therefore we studied selected exoU positive
MDR strains of P. aeruginosa displaying unusually high
adherence and disrupting properties against the intestinal
epithelium and determined whether surface structures might
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intestinal epithelial cells. In this report we show that these
strains express previously un-described appendages that
contain signiﬁcant quantities of PstS, a high afﬁnity phos-
phate binding protein. We characterized the structural and
functional aspects of these PstS rich appendages and
determined that they play a signiﬁcant role in the adherence
to and disruption of intestinal epithelial cells. Outer surface
expression of PstS rich appendages was induced under low
phosphate conditions and suppressed in high phosphate
media. Lethality assays in a mouse model of gut-derived sepsis
in which low phosphate conditions are known to exist,
demonstrated high lethality rates that were completely
abrogated when mice were supplemented with intestinal
phosphate. Taken together, these data provide evidence that
low phosphate conditions increase the presence of PstS rich
appendages on MDR P. aeruginosa whose presence facilitates
binding to the intestinal epithelium and whose expression in
vivo may play a signiﬁcant role in the development of gut-
derived sepsis in critically ill patients.
Results
Highly Virulent MDR P. aeruginosa Express Novel
Appendage-Like Structures
In our previous work we screened consecutive MDR P.
aeruginosa clinical isolates and identiﬁed a subset of strains
that displayed a highly destructive phenotype against
cultured intestinal epithelial cells (Caco-2 bbe) [2]. Among
this subset of isolates, high swimming motility, increased
adhesiveness to Caco-2 monolayers, and the presence of the
exoU gene predicted a cytotoxic phenotype against the
intestinal epithelium [2]. In the present study, we screened
these highly adhesive MDR clinical isolates by their cell
surface morphology using electron microscopy, and identi-
ﬁed appendage-like structures on the surfaces of the most
cytotoxic isolates (1, 13, and those of genotype 20) (Figure
1A–1D and Table 1). The identiﬁed appendages were 20 nm
in diameter, up to 500 nm in length, and were visually distinct
from ﬂagella (Figure 1A and 1D). The identiﬁed appendages
were not detected on any of the remaining clinical isolates of
the previously reported series of strains (see Figures S1 and
S2).
Identification of Proteins Involved in the Formation of
Novel Appendages
To identify proteins involved in the formation of the
visualized appendages, surface-associated proteins were
obtained by extensive vortexing of bacterial cells grown on
Pseudomonas isolation agar (PIA), denatured by boiling with
sample buffer and then separated by 10% Tris-glycine SDS-
PAGE. Figures 2A and 2B show the presence of abundant
protein bands at an approximate MW of 32 kDa from surface
sheared proteins in strain MDR25 (Figure 2A, lane 2); 32 and
40 kDa bands from strain MDR1 (Figure 2A, lane 3); and a 40
kDa band from strain MDR13 (Figure 2B, lane 2). Proteins
were transferred to a PVDF membrane and N-terminal
sequencing of the 32 and 40 kDa proteins in strain MDR1
and the 40 kDa protein in strain MDR13 were performed with
ABI-Procise cLC Protein Sequencer (Mayo Proteomics
Research Center). The N-terminal peptide sequence of the
32 and 40 kDa proteins in strain MDR1 were found to be
AIDPALPEYQK and EINGGGATLPQQLXQEPGV, respec-
tively. The N-terminal peptide sequence of 40 kDa protein
in strain MDR13 was identiﬁed as DINGGGATLPQQLYQ.
The peptide sequences were searched with BLAST, and the
best hit of the 32 kDa band sequence was found to be the PstS
protein PA5369 in P. aeruginosa PAO1. The sequence
AIDPALPEYQK was located to aa 25–35 on ORF PA5369.
PA5369 was demonstrated to contain a cleavable type I signal
peptide of 24 aa [6], therefore the 32 kDa protein in strain
MDR1 might correspond to periplasmic orthologous protein
PA5369 in PAO1. The best hit of the 40 kDa band sequence in
both strains 1 and 13 was found to be PA55410 from P.
aeruginosa PA14 (http://v2.pseudomonas.com/getAnnotation.
do?locusID¼PA14_55410). The sequence DINGGGATLPQQ-
LYQ was located to aa 24–38 on ORF PA55410. Orthologous
to PA55410, PA0688 protein in PAO1 was also demonstrated
to contain a cleavable type I signal peptide of 23 aa,
MFKRSLIAASLSVAALVSAQAMA [6], which was 100% iden-
tical to N-terminus of PA55410. Therefore the 40 kDa
proteins in strains 1 and 13 might be orthologous to
PA55410 in P. aeruginosa PA14 [7], the strain known to be
highly virulent, and PA0688 from P. aeruginosa PAO1.
We next ampliﬁed and sequenced genes analogous to
pa5369 in MDR strains 1, 13, and 25 (GenBank Accession
numbers EF601157, EF601158, and EF601159). We deter-
mined them to be very conserved with few differences in
nucleotide sequences that did not affect amino acid
sequences which were 100% identical to PA5369 in P.
aeruginosa PAO1 (http://www.pseudomonas.com/). We there-
fore created anti-PA5369 antibodies against the speciﬁc
peptide 192–212 KEEALCKGDFRPNVNEQPGS that was
chosen based on hydrophobicity, surface probability, ﬂexi-
bility, and antigenic index, as well as the Advanced BLAST
Search for the absence of signiﬁcant homology to other P.
aeruginosa proteins. Antibodies were subjected to afﬁnitive
puriﬁcation using the native peptide 192–212, and then used
to detect appendage-like structures in the clinical isolates.
We ﬁrst performed immunobloting of cell surface structures
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Author Summary
The resistance of bacteria to multiple antibiotics is a major problem
in critically ill patients who often become colonized by highly lethal
pathogens such as Pseudomonas aeruginosa. During the course of
critical illness, as many as 50% of patients’ intestinal tracts become
colonized with P. aeruginosa, with as many as 30% of strains being
resistant to multiple antibiotics. Concomitantly, critical illness is
characterized by acute depletion of phosphate, which itself has
been shown to be an independent predictor of infection-related
mortality. In the present study we determined that during low
phosphate conditions, highly virulent multi-antibiotic–resistant
strains of P. aeruginosa isolated from critically ill patients produce
an abundance of the phosphate-binding protein, PstS, located on
extracellular finger-like structures. These PstS rich appendages
participate in the binding of P. aeruginosa to intestinal lining cells
and may allow P. aeruginosa to acquire phosphate from its host
while remaining at arm’s length from the host immune system. This
clever tactic may be one example by which successful opportunistic
pathogens such as P. aeruginosa survive within complex ecological
niches such as the intestinal tract and harm their hosts during the
course of critical illness.using anti-192–212 peptide antibodies, now referred to as
anti-PA5369 antibodies, and found high antibody afﬁnity to
cell surface proteins of strain MDR25, moderate afﬁnity to
strains MDR1 and MPAO1, and minimal afﬁnity to strain
MDR13 (Figure 2C). These data corresponded to the results
of the SDS-PAGE demonstrating an abundance of the 32 kDa
protein band in strain MDR25 but not in strain MDR13. The
speciﬁcity of the anti-PA5369 antibody was conﬁrmed by
examining both sheared appendages and bacterial pellets in
wild-type MPAO1, PA5369 mutant, and clinical strain MDR25
(Figure 2D). Results demonstrated that anti-PA5369 recog-
nized abundant amounts of protein in both the cell pellet
and sheared appendages in strain 25. In strain MPAO1,
antibodies recognized an abundant amount of protein in the
cell pellet but a low amount in sheared appendages. No
recognizable protein in either the cell pellet or sheared
surface fractions in the MPAO1 mutant DPA5369 was
observed. ELISA assays performed with sheared proteins
from different clinical isolates (Figure 2E) demonstrated the
presence of highly abundant PA5369-like protein in MDR
clinical strains 25, 27, and 28, all of which share the same
genotype 20. Interestingly, anti-PA5369 antibodies recog-
nized signiﬁcantly lower amount of proteins in sheared
fractions isolated from other clinical isolates previously
shown to be unable to alter the epithelial resistance of
Caco-2 monolayers (see Table 1) [2]. Another interesting
ﬁnding was the presence of PA5369 in sheared fractions of
MPAO1 by both ELISA (Figure 2E) and immunobloting
(Figure 2D), although much lower in abundance compared to
the highly adherent strains MDR25 and MDR1. PA5369 has
been predicted by COG (Clusters of Orthologous Groups,
http://www.pseudomonas.com/) to be PstS, a phosphate trans-
port system substrate-binding protein whose expression in P.
aeruginosa is induced at phosphate concentrations , 1m M
[8–12]. In order to determine if the formation of appendages
in clinical isolate 25 was phosphate dependent, we suspended
a single colony in 10% glycerol, and plated equal amounts on
either PIA that we measured to contain 300 lM of phosphate
or PIA supplemented with 1 mM K-phosphate buffer, pH 7.0.
Cells grown on these plates were analyzed for the presence of
appendages by transmission electron microscopy (TEM) and
immunobloting. TEM images clearly demonstrated the
Figure 1. Multi-Drug–Resistant P. aeruginosa Clinical Isolates Display Unusual Appendage-Like Structures on the Cell Surface
Transmission electron microscopy (TEM) images of MDR virulent clinical isolates at magnification of 15,000 3 1.4.
(A) Strain MDR1.
(B) Strain MDR13.
(C) Strain MDR25.
(D) Strain MDR26.
Novel appendage-like structures are shown by black arrows. For comparison, flagella are indicated by grey arrows.
doi:10.1371/journal.ppat.0040043.g001
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PstS-Containing Appendages on MDR P. aeruginosaabsence of appendages in strain MDR25 grown on phos-
phate-enriched PIA (Figure 2F) and an abundance of
appendages in the same strain grown on PIA only (Figure
2G). We also noted the differences in colony phenotype when
smooth surface colonies appeared on high Pi media (Figure
2Fa), and rough surface colonies appeared on low Pi media
(Figure 2Ga). Immunoblot analysis (Figure 2H and 2I)
demonstrated the absence of proteins recognized by anti-
PA5369 antibody on phosphate rich media versus their
abundance on phosphate poor media in both sheared cell
surface fractions (Figure 2H) and cell pellets (Figure 2I).
Finally, we performed immuno-gold electron microscopy of
strain MDR25 to conﬁrm the presence of PstS protein on the
appendages. Whole cells of strain MDR25 were directly
harvested from PIA plates and incubated with anti-PA5369
antibody followed by incubation with gold-labeled goat anti-
rabbit antibody. Figure 2J demonstrates gold spots localized
on the cell surface structures in strain MDR25. Gold spot
localization was not observed in negative controls performed
in the absence of primary anti-PA5369 antibodies (data not
shown). We noted the fragility of these appendages on EM as
detached and fragmented appendages were observed (see
Figure S3).
The PstS-Like Protein Contributes to the Ability of P.
aeruginosa MDR25 and MPAO1 to Adhere to and Disrupt
the Integrity of Cultured Intestinal Epithelial Cells
In order to determine the contributory role of the PA5369-
like protein on the ability of MDR P. aeruginosa to adhere to
and disrupt barrier function of cultured intestinal epithelial
cells, we examined the effect of anti-PA5369 antibodies on
the adhesiveness and barrier disrupting capability. In order
to avoid the non-speciﬁc interference of whole antibodies, we
puriﬁed Fab fragments of anti-PA5369 antibodies to use in
these experiments. Using stain MDR25, we performed
adhesion assays to Caco-2 monolayers and determined the
transepithelial resistance (TER) of Caco-2 cells, a measure of
barrier function, in the presence or absence of Fab fragments
of anti-PA5369 antibodies. Both the adhesiveness of strain
MDR25 to Caco-2 monolayers (Figure 3A) and the ability of
strain MDR25 to disrupt the TER of Caco-2 monolayers
(Figure 3B) were signiﬁcantly attenuated when pre-incubated
with the Fab fragments of anti-PA5369 antibodies.
In order to determine if PstS could inﬂuence the ability of
non-multi-drug resistant strains to alter intestinal barrier
function, we performed complementary experiments using P.
aeruginosa MPAO1 and its derivative mutant DPA5369 [13].
The mutant DPA5369 was complemented with the pa5369
gene on a multi-copy plasmid pUCP24 (D5369/pa5369). First
strains were veriﬁed for the presence of surface-associated
PstS by ELISA using speciﬁc anti-PA5369 antibodies (Figure
3C). In order to determine if PstS contributed to the
adhesiveness of MPAO1, we apically inoculated Caco-2
monolayers with P. aeruginosa strains and assessed the degree
of adhesiveness after one hour of co-incubation. We observed
the adhesiveness of MPAO1 to cultured intestinal epithelial
cells to be as low as 1% of the initial inoculum; an effect that
was further decreased with the mutant strain D5369 (Figure
3D). Strain D5369/pa5369 demonstrated increased adhesive-
ness to Caco-2 cells compared to both the wild type and 5369
mutant (Figure 3D). Reiterative experiments were then
performed to assess the ability of the strains to alter epithelial
barrier function, as measured by TER of Caco-2 cells. We
have previously reported strain MPAO1 to display low
virulence against Caco-2 monolayers (;5% decrease in TER
at 3 hours) compared to clinical strain MDR25 (;70%
decrease in TER at 3 hours) (see Table 1). However at later
time points (7 hours) strain MPAO1 decreased resistance of
Caco-2 monolayers by 60%–70%. Therefore, we measured
TER after 7 hours of co-incubation of Caco-2 cells using
MPAO1 and its derivatives and found that strain D5369 was
signiﬁcantly attenuated in its ability to decrease the TER of
Caco-2 monolayers (Figure 3E). Complementation of D5369
with pa5369 gene restored its effect to decrease the TER of
Caco-2 cells similar to the wild type PAO1 (Figure 3E).
Smooth Versus Rough Appearing Colonies of MDR25
Differentially Express Surface-Exposed PstS and
Differentially Induce Mortality in a Mouse Model of Gut-
Derived Sepsis
We incidentally noticed the spontaneous appearance of
smooth colonies among rough-edged colonies of MDR25
when grown on PIA where the phosphate level (Pi) was
determined to be ;300 lM (Figure 4A, black arrows). When
smooth colonies were isolated and re-plated on PIA, the
rough-edged colonies re-appeared interspersed among
smooth colonies (Figure 4B, shown by white arrow) suggesting
the possibility of colony phase variation. We also noted that
rough (MDR25R) and smooth (MDR25S) colonies were
distinct in their production of bioﬁlm, whereby MDR25S
produced signiﬁcantly greater amounts of bioﬁlm compared
to MDR25R (Figure 4C). Growth curves for MDR25S and
MDR25R were similar in liquid Pseudomonas broth (see Figure
S4). We next examined smooth and rough colonies for their
Table 1. Virulence Characteristics of MDR P. aeruginosa Clinical
Isolates Assessed by Their Ability to Adhere to (% Adhesion) and
Alter the Transepithelial Electrical Resistance (% Decrease in
TER) of Caco-2 Cells [2]
Strain Genotype Percent Decrease
in TER at 3 h
Percent
Adhesion
Highly virulent MDR
clinical isolates
11  77 6 4.8 23 6 5.0
13 13  71 6 3.3 22.9 6 0.71
25 20  60 6 6.7 19 6 1.79
27 20  54 6 8.0 18.85 6 4.9
28 20  59 6 2.5 24.0 6 1.25
Low and non-virulent
MDR clinical isolates
77  4 6 4.9 0.5 6 0.4
33 33  3 6 5.8 0.5 6 0.01
16 16  3.0 6 3.0 1.63 6 0.74
66  3.0 6 2.5 7.4 6 2.9
99  2.0 6 2.8 4.93 6 0.5
22  1.0 6 1.77 3.1 6 1.96
88 0 6 5.4 0.83 6 0.08
19 19 1.0 6 0.46 0.5 6 0.01
11 11 þ5.0 6 6.9 5.35 6 2.27
15 15 þ6.95 6 0.2 12.6 6 3.9
31 31 þ8 6 2.9 0.5 6 0.01
17 17 þ19 6 5.8 0.5 6 0.01
doi:10.1371/journal.ppat.0040043.t001
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PstS-Containing Appendages on MDR P. aeruginosaPstS content on surface sheared fractions by ELISA using
anti-PA5369 antibodies and determined that smooth edge
colonies produced signiﬁcantly less PstS compared to rough
colonies (Figure 4D). Finally, we determined if MDR25R and
MDR25S differentially induced mortality in mice using an
established model of lethal gut-derived sepsis [14,15]. This
model involves creating a surgical stress with a 30%
hepatectomy and simultaneous intestinal exposure to P.
Figure 2. Identification of Appendage-Like Structures
(A, B) Fractionation of sheared cell surface proteins by 10% Tris-Glycine SDS-PAGE and identification of abundant proteins by N-terminal sequencing.
(A), Lane 1, molecular weight standards (Bio-Rad, broad range, pre-stained); lane 2, strain MDR25; lane 3, strain MDR1. Black arrows show proteins of
strain MDR1 subjected to N-terminal sequencing.
(B) Lane 1, molecular weight standards (Invitrogen, SeeBlue Plus 2 pre-stained); lane 2, strain 13. Black arrow shows protein subjected to N-terminal
sequencing.
(C) Immunoblot analysis of cell surface sheared proteins isolated from strains MDR1, MDR13, MDR25, and MPAO1 by using affinity purified polyclonal
anti-PA5369 antibody.
(D) Immunoblot analysis of pellet and sheared surface proteins from strains MPAO1, MPAO1 derivative PA5369 mutant, and clinical strain MDR25.
Colonies were collected and suspended in 200 ll PBS up to final density of 5.0 (600 nm) followed by vortexing for 2 min and centrifuging at 5,000g,5
min. Sheared material in 10 ll of supernatant was denatured by boiling with 10 ll sample buffer and 10 ll was loaded on gel wells to be separated by
10% glycine SDS-PAGE. The remaining pellet was resuspended in 50 ll of sample buffer, boiled, and 2 ll were loaded on gel wells. PstS protein was
identified by immunoblot using anti-PA5369 antibody.
(E) Enzyme-linked immunosorbent assay (ELISA) to detect PA5369-like protein on cell surfaces of MPAO1 and MDR clinical P. aeruginosa strains. Data are
mean 6 SD (n ¼ 3).
(F, G) TEM images of strain MDR25 grown on (F) PIA supplemented with 1 mM K-phosphate buffer and (G) on PIA.
(H, I) Immunoblot of (H) sheared surface proteins and (I) cell pellet proteins in strain MDR25 grown on PIA (low phosphate) versus PIA supplemented
with 1 mM K-phosphate buffer (high phosphate).
(J) Immuno-electron microscopy of strain MDR25. Gold spots identified with arrows indicate the protein recognized by anti-PA5369 antibody on cell
surface structures.
doi:10.1371/journal.ppat.0040043.g002
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PstS-Containing Appendages on MDR P. aeruginosaaeruginosa via direct injection into the cecum [15]. This model
is of particular clinical relevance as it is well established that
surgical hepatectomy results in severe hypophosphatemia
[16]. Rough and smooth colonies were suspended in 10%
glycerol at OD 0.25 (600 nm) and injected into the cecum at
the time of hepatectomy. Mice were followed for 48 hours for
mortality. Results demonstrated that mice injected with the
smooth edged, PstS poor strain MDR25S displayed 10%
mortality at 48 hours whereas mice injected with the rough
edged PstS rich strain MDR25R, displayed 60% mortality at
48 hours (Figure 4E). Data were analyzed using Kaplan-Meier
survival curves with SPSS software, n ¼ 10/group, p ¼ 0.021.
Phosphate Supplementation Protects Mice from Lethality
Following Intestinal Exposure to either MDR25R or MDR1
We determined if phosphate supplementation in mice
subjected to a 30% hepatectomy, could prevent lethality due
to MDR25R or MDR1 by performing reiterative experiments
in which mice were fed varying concentrations of phosphate
([Pi]). Group 1 (n ¼ 8) were fed water only, Group 2 (n ¼ 8)
were fed 0.2x PBS (phosphate buffered saline, pH 7.4, [Pi]¼2
mM) as their drinking water, and Group 3 (n¼5) were fed 1x
PBS ([Pi]¼10 mM) as their drinking water for 36 hours before
surgical hepatectomy and injection of bacteria. In addition,
Figure 3. PA5369 Is Involved in Adhesiveness and Ability of MDR25 and MPAO1 to Disrupt Epithelial Integrity
(A) Anti-PA5369 antibodies decrease the adhesiveness of strain MDR25 to Caco-2 monolayers. Strain MDR25 was grown on PIA plates for 2 days,
bacteria were harvested, resuspended in PBS to a cell density of 5.0, and 2 ll was added to the apical surface of confluent Caco-2 cells. The Fab
fragments of anti-PA5369 antibody at dilution 1:100 were included in the DMEM media (when needed) at the point of inoculation. Following 1 hour of
incubation at 378C, 5% CO2, the percentage of adherent cell was calculated. Data are mean 6 SD (n ¼ 3), p , 0.001 (Student t-test).
(B) Anti-PA5369 antibodies attenuate the ability of strain MDR25 to disrupt Caco-2 monolayer integrity. Strain MDR25 was grown on PIA plates for 2
days, bacteria were harvested, resuspended in PBS to a cell density of 5.0, and 2 ll was added to the apical surface of confluent Caco-2 cells grown in
transwells. The Fab fragments of anti-PA5369 antibody at dilution 1:100 were included in the DMEM media at the point of inoculation. Transepithelial
resistance (TER) was measured dynamically as previously described [2]. The control group reflects the TER of Caco-2 cells in the absence of MDR25. Data
are mean 6 SD (n ¼ 3), p , 0.005 (Student t-test).
(C) Detection of surface associated PstS by ELISA in strain MPAO1 and derivative strains. Data are mean 6 SD (n ¼ 3), p , 0.001 (Student t-test).
(D) PA5369 is involved in the adhesiveness of MPAO1 to Caco-2 cell monolayers. MPAO1 and its derivative strains were grown in TSB overnight, and 2 ll
added to the apical surface of confluent Caco-2 cells. Following 1 hour of incubation at 378C, 5% CO2, the percentage of adherent bacteria was
calculated as previously described [2]. Data are mean 6 SD (n ¼ 3), p , 0.005 (Student t-test).
(E) PA5369 is involved in the ability of MPAO1 to disrupt Caco-2 monolayer integrity. MPAO1 and its derivative strains were grown in TSB overnight, and
2 ll added to the apical surface of confluent Caco-2 cells grown in transwells. Transepithelial resistance (TER) of Caco-2 cells was measured after 7 hours
of co-incubation with P. aeruginosa strains. Data are mean 6 SD (n ¼ 3), p , 0.005 (Student t-test)
doi:10.1371/journal.ppat.0040043.g003
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PstS-Containing Appendages on MDR P. aeruginosaprior to injection of MDR25R into the cecum, bacteria were
suspended in either water containing 10% glycerol (group 1)
or 0.2x PBS (group 2) or 1x PBS (group 3). Results shown in
Figure 5A demonstrate that MDR25R caused 100% mortality
within 48 hours when mice drank water only (Group1)
whereas mice drinking a water solution containing 2 mM
phosphate (Group 2) had signiﬁcantly decreased mortality
(50%) while mice drinking a water solution containing 10 mM
phosphate (Group 3) had no mortality (100% survival). Data
were analyzed using Kaplan-Meier surviving curves in SPSS
software, p ¼ 0.004. Similar results were found in reiterative
experiments with the clinical isolate MDR1 (Figure 5B) (n ¼
10, p ¼ 0.001).
The Alternative Type II Secretion System hxc Contributes
to Outer Surface Expression of PA5369
The outer surface expression of PstS PA5369 observed in
the current study is at variance with its previously reported
characterization as a periplasmic protein. In order to clarify
this we hypothesized that knockout of adjacent low phos-
phate responsive elements might impair the surface expres-
sion of PstS. PstS PA5369 is clustered to the phosphate ABC
transporter locus (Figure 6A). Based on the KEGG SSDB
(Kyoto Encyclopedia of Genes and Genomes Sequence
Similarity DataBase http://www.genome.jp/kegg/ssdb/) search,
PstS PA5369 can be considered as a paralogous protein of
PstS PA0688 in P. aeruginosa PAO1 that is clustered to the
alternative type II secretion locus (Figure 6B). According to
recent data [17], PA0688 is characterized as alkaline
phosphatase that is secreted by the alternative type II
secretion system Hxc induced under low phosphate con-
ditions. We therefore hypothesized that hxc might also play a
role in the outer surface expression of PstS PA5369 and
performed immunoblot analysis of sheared appendages in
strains P. aeruginosa PAO1 and its derivative mutant DHxcR
(PA0686). As shown in Figure 6D, the DHxcR mutant was
attenuated in the production of the outer surface but not
intracellular PA5369 suggesting at least partial involvement
of hxc system to present PstS on outer surface appendages.
Moreover, complementation of the mutant with hxcR
restored its ability to express outer surface PstS (Figure 6D),
conﬁrming involvement of the Hxc system. N-terminal
sequence of proteins from sheared fractions of the MDR
isolates 1 and 13 by Blast Search correspond to PA14–55410
which is orthologous to PA0688 and clusters to the hxc system
Figure 4. Colony Morphology Variation in MDR25 Correlates with Production of Outer Surface-Exposed PstS and Virulence
(A) The appearance of smooth edged colonies as shown by black arrows in MDR25 grown on PIA, Gm 50 lg/ml.
(B) A single smooth colony was isolated, cultivated in PB, Gm 50 lg/ml, and plated on PIA, Gm 50 lg/ml. The appearance of rough edged colony is
shown by the white arrow.
(C) Biofilm production by rough (MDR25R) and smooth (MDR25S) strains grown in PB, Gm 50 lg/ml.
(D) Expression of outer surface PstS in MDR25R and MDR25S grown on PIA, Gm 50 lg/ml.
(E) Kaplan-Meier survival curves of mice intestinally inoculated with MDR25S or MDR25R demonstrating attenuated killing effect of MDR25S. n ¼ 10/
group, p ¼ 0.021.
doi:10.1371/journal.ppat.0040043.g004
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gene in strain MDR1, and found that the protein encoded by
this gene had 90% identity to PA14 55410 from P. aeruginosa
PA14, 45.3% identity to PA0688 from P. aeruginosa PAO1, and
64.3% identity to the human plasma phosphate-binding
protein HPBP which is classiﬁed as a DING protein [18–20].
We therefore named the protein from MDR1 as DING and its
respective gene dinG (GenBank Accession number EF616488).
We next performed experiments to determine the expression
level of pstS and related genes from the phosphate ABC
transporter system, pstS pa5369, phoB and phoU, as well as pstS
and related genes from hxc system, pa0688, dinG, and hxcX,a
gene of hxc operon (Figure 6A–6C). We examined four strains:
MPAO1, MDR1, MDR25R, and MDR25S. Strains were grown
overnight on PIA and PIA complemented with 10 mM K-Ph
buffer, pH 7.0, and RNA was directly isolated from cell
colonies. Results are presented in Figure 6E. While the
expression of the housekeeping enzyme citrate synthase
demonstrated no signiﬁcant change in response to phosphate
limitation, the expression of all genes tested was increased in
response to low phosphate media with each expressing a
distinct pattern. While a similar increase in phoU expression
was observed between all strains, only a modest increase in
phoB expression was detected in MDR25R compared to other
strains. Similarly only a modest increase in pstS pa5369
expression was observed in the MDR isolates compared to
MPAO1. The most intriguing ﬁnding however was that,
although pstS pa5369 expression was similar between the
rough (high outer surface PstS) and smooth (low outer surface
PstS) colony variants, a dramatic difference in expression was
observed in the hxc operon. In fact, hxcX expression was ten
times higher in MDR25R compared to MDR25S. The low
response of hxcX to phosphate limitation was also observed in
MPAO1 strain compared to MDR25R and MDR1. Although
the expression of pa0688, the orthologous of DING protein in
MPAO1, was 20-fold higher at low phosphate concentrations,
this effect was small compared to that observed for MDR
strains where a 150-fold increase was observed with MDR25S,
a 1,400-fold in MDR25R, and 5,000-fold increase in expres-
sion in MDR1.
Discussion
Numerous reports have documented that the rise in MDR
nosocomial pathogens continues to threaten hospitalized
patients despite the implementation of various counter-
measures including isolation techniques and antibiotic de-
escalation measures [21]. While the mere culture of a MDR
resistant pathogen such as P. aeruginosa is perceived to be a
real and present danger to patients primarily because it
cannot be readily eliminated by antibiotics, the evidence that
antibiotic resistance itself confers a more virulent phenotype
is highly variable. Our previous work on screening consec-
utively isolated MDR strains of P. aeruginosa from critically ill
hospitalized patients demonstrated that strains express
extremely polar virulence phenotypes against the intestinal
epithelium from those that are essentially inert, to those that
are highly motile, adhesive, and destructive [2]. In fact among
the consecutively collected strains in this series, only a
minority of strains displayed a virulent phenotype against the
intestinal epithelium (;15%). A better understanding of the
virulence determinants of MDR P. aeruginosa and their
mechanism of action against the intestinal epithelium is
important given the high prevalence of colonization of this
organism in the intestinal tract of critically ill and immuno-
compromised patients [22–24].
Human critical illness represents a unique ecological niche
for P. aeruginosa because of its prolonged exposure to
antibiotics and physiologic disturbances that have no
historical precedent in terms of host survival. Extensive life
sustaining measures employed during the care of the
critically ill such as the use of gastric acid suppression
Figure 5. Intestinal Phosphate Supplementation Prevents the Lethality of MDR Strains in Mice
Seven-week-old male C57BL6 mice were given either water (no phosphate supplementation), or 2 mM PBS solution (2 mM phosphate
supplementation), or 10 mM PBS solution (10 mM phosphate supplementation) for 36 hours prior to hepatectomy. P. aeruginosa MDR25 was grown
overnight in Pseudomonas broth (PB) containing Gm, 50 lg/ml, cells were collected by centrifugation, resuspended in either water containing 10%
glycerol (group 1, n¼8), or 2 mM PBS (group 2, n¼8) or 10 mM PBS (group 3, n¼5) to final OD600 nm 0.2, and 200 ll of bacterial solutions were injected
into cecum immediately after hepatectomy. The abdomen was closed and mice were allowed to drink either water (group 1) or 2 mM PBS (group 2) or
10 mM PBS (group 3) and followed for mortality. Data were analyzed using Kaplan-Maier survival curves with SPSS software and significance tested by
Log-rank (Mantel-Cox) p ¼ 0.004. Reiterative experiments were performed with the clinical isolate MDR1 with the exception that only 10 mM of
phosphate supplementation was tested (n ¼ 10/group, p ¼ 0.001).
doi:10.1371/journal.ppat.0040043.g005
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PstS-Containing Appendages on MDR P. aeruginosaFigure 6. Alternative Type II Secretion System Is Involved In Outer Surface Expression of PstS
(A) Clustering of pstS pa5369 to the P. aeruginosa PAO1 genome.
(B) Clustering of pstS pa0688 to the P. aeruginosa PAO1 genome.
(C) Clustering of pstS pa14–55410 to P. aeruginosa PA14 genome.
(D) Immunoblot analysis of pellet and sheared surface proteins from strains MPAO1, MPAO1 derivative PA0686 (DHxcR) mutant, and DHxcR
complemented mutant. Strains were grown on PIA, and colonies collected and suspended in 200 ll PBS containing protease inhibitor cocktail (Sigma)
up to final density of 5.0 (600 nm) followed by vortexing for 2 min and centrifuging at 5,000g, 5 min. Sheared material in 10 ll of supernatant was
denatured by boiling with 10 ll sample buffer and 10 ll was loaded on gel wells to be separated by 10% glycine SDS-PAGE. The pellet was resuspended
in 50 ll of PBS containing protease inhibitor cocktail, and 150 ll of BugBuster Master Mix (Novagen) was added to lyze the bacterial cells. Debris was
removed by centrifugation, and 10 ll of supernatant was denatured by boiling with 10 ll sample buffer and 10 ll was loaded on gel. PstS protein was
identified by immunoblot using anti-PA5369 antibody.
(E) Expression of pstS and pstS-related genes under phosphate limitation determined by Real-Time RT-PCR. Gene expression was performed in triplicate
with data representing the mean, and three independent experiments run showing similar expression patterns. The (-RT) controls were determined to
be at the level of blank control (no template included).
doi:10.1371/journal.ppat.0040043.g006
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hypoxia, continued use of opioids that impair the ability of
the intestinal tract to excrete non-commensal pathogens, and
the delivery of highly processed artiﬁcial nutrition, all favor
the exposure of pathogens like P. aeruginosa to a composite of
environmental cues that can directly activate its virulence
circuitry [25–29]. In this regard a major environmental cue
within the intestinal tract that could shift the virulence of P.
aeruginosa to that of a more virulent phenotype against the
epithelium may be low extracellular phosphate which is often
present during severe critical illness [16,30–32]. Hypophos-
phatemia is reported to be present following a variety of
physiologic stress states such as myocardial infarction [33],
ischemia-reperfusion injury [33], major liver resection [16],
use of insulin to control hyperglycemia [34,35], use of
intravenous nutrition [36,37], and during sepsis [38]. In such
circumstances, phosphate depletion appears to be severe and
an independent predictor of mortality due to infection and
sepsis [38]. While the mechanisms for this observation are
unknown, it is possible that colonizing strains of P. aeruginosa
present in the intestinal lumen of critically ill patients
become activated to express a more virulent phenotype
against the intestinal epithelium in response to low phos-
phate concentrations resulting from surgical injury and
catabolic stress.
In the present study, we determined that MDR P. aeruginosa
clinical strains displaying a high degree of virulence against
cultured intestinal epithelial cells express an extraordinary
amount of surface-associated PstS proteins orthologous to
PA5369 from P. aeruginosa PAO1 and PA14 55410 protein
from P. aeruginosa PA14. The observation that PstS on
appendages contributes to intestinal epithelial adherence
coupled with its known role as a phosphate binding protein,
raises the possibility that the PstS present on appendages
might facilitate the ability of MDR P. aeruginosa to acquire
phosphate from intracellular stores within the host. This
latter effect appeared to be dependent on the presence and
expression of the alternative type II secretion system Hxc,
which itself is activated in the presence of low phosphate [17].
This ﬁnding establishes a link between the phosphate binding
ABC transporter and the Hxc system in P. aeruginosa.
Simultaneous expression of both systems is necessary for
the formation of outer surface PstS-rich appendages as
neither DPstS nor DHxcR mutants produce them in P.
aeruginosa MPAO1. Both the PstS and the Hxc systems are
highly inducible in MDR clinical isolates that express a
particularly adhesive and barrier disrupting phenotype
against intestinal epithelial cells. In this regard, certain
MDR P. aeruginosa strains may have adapted unique genetic
changes in response to unusually harsh selective pressures
that typify critically ill humans including multiple antibiotic
use, severe hypoxia, and the ability to sustain life with
prolonged intravenous nutrition. Among such changes may
be the ability to acquire phosphate and other nutrients from
within host cells given that physiologic stress and tissue injury
are know to shift phosphate into the intracellular compart-
ment resulting in severe hypophosphatemia [39]. Under such
circumstances outer surface expression of PstS on appen-
dages may confer an evolutionary advantage to P. aeruginosa
by expressing phosphate acquiring structures capable of
scavenging intracellular phosphate at arm’s length from the
host immune system.
Data from the present study are not the ﬁrst to
demonstrate that PstS is secreted by bacteria during nutrient
manipulation of the media. For example, it has been recently
reported that Streptomyces lividans secretes PstS into liquid
cultures containing high concentrations (.3 %) of certain
sugars, such as fructose, galactose, and mannose [40]. Another
example in which PstS has been shown to be secreted is
PA0688 protein in P. aeruginosa PAO1. Inquiry of the PA0688
protein into the ‘‘Clusters of Orthologous Groups (COG)
Program’’ predicted it to be PstS. However PA0688 clusters to
the hxc loci and has been shown to be secreted by the Hxc
system under phosphate depleted conditions and functions as
alkaline phosphatase [17]. In the current study, the proteins
identiﬁed in MDR P. aeruginosa orthologous to PA0688 were
expressed several hundred fold higher than in MPAO1. That
sequence analysis revealed this protein in MDR1 to belong to
DING proteins is intriguing, given that the origin and
function of DING proteins have remained a focus of
speculation. DING proteins are characterized by their N-
terminal DINGGGATL-sequence and are highly conserved in
both animal and plants, although they are more variable as
microbial proteins [19,41–43]. There are some functional
similarities between DING proteins from pro- and eukaryotes
including structural homology with phosphate-binding pro-
teins [19,43]. It has been hypothesized that pathogenic or
symbiotic bacteria might acquire the DING gene via
horizontal gene transfer from eukaryotes in order to sense
and respond to host signals or to modify intercellular
signaling pathways in host cells [42]. Others have suggested
that DING proteins do not exist in eukaryotes at all, and that
their detection in human tissues has been a result of
microbial contamination or infection [41]. Based on the
codon usage analysis of DNA, it has been assumed that DING
sequences found in eukaryotes are of Pseudomonas origin [41].
Further work is in progress to characterize the role of the
DING-protein related appendages found in this series of
MDR clinical isolates, the results of which may add to our
understanding of the impact of bacterial DING proteins on
the modulation of signal transduction in animals.
The gene pstS pa5369 is part of the pst operon encoding a
speciﬁc phosphate transport system that is activated under
low phosphate conditions. The high afﬁnity phosphate
transport system pst belongs to the Pho regulon that is
controlled by the two-component regulatory system PhoB/
PhoR, which responds to local phosphate concentration.
PhoB/PhoR is highly conserved and widely present in Gram
negative and Gram positive microorganisms. In addition,
PhoB/PhoR controls the expression of multiple genes [44,45]
many of which are involved in phosphate uptake and
metabolism and various other metabolic pathways such as
the de novo biosynthesis of NAD [46], the initiation of
chromosome replication [47], the acid shock response [48],
the RpoS-mediated stress response [49], and AMP hydrolysis
[44,50]. The phosphate regulon might be also involved in the
activation of quorum sensing in P. aeruginosa as evidenced by
the recent observation that the transcriptional activation of
rhlR and production of PQS and pyocyanin develop during
phosphate limitation [12]. Furthermore, a link between the
expression of the ABC phosphate transporter and penicillin
resistance in Streptococcus pneumoniae has been reported
thereby proposing a novel role for PstS [51]. These
investigators reported that the pstS gene product was over-
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resulted in penicillin sensitivity [51]. Further evidence linking
PstS to antibiotic resistance has been demonstrated in
ﬂuoroquinolone resistant Mycobacterium smegmatis [52] where
ampliﬁcation of the phosphate speciﬁc transporter suggested
that the efﬂux mediated ﬂuoroquinolone resistance might be
an intrinsic function of the Pst system [52–54]. Thus is it
plausible that the development of multi-drug resistance in P.
aeruginosa clinical isolates MDR1, MDR13, and MDR25 might
be related to the overproduction of PstS proteins.
Mouse lethality experiments from the present study
strongly suggest a signiﬁcant role for PstS in the virulence
of MDR25R P. aeruginosa virulence in vivo. The importance of
PstS in in vivo virulence has been previously addressed in
various models including a mouse infection model using
Mycobacterium tuberculosis and pstS1 and pstS2 knockout strains
[55], a ﬁsh infection model using Edwardsiella tarda,a
facultative aerobic enterobacterium that causes hemorrhagic
septicemia in ﬁsh and gastrointestinal infections in humans
[56], and a chicken infection model using Escherichia coli O78,
an organism associated with extraintestinal infections and
septicemia in poultry, livestock, and humans [57].
In summary, we have identiﬁed PstS-rich appendage-like
structures on the outer surfaces of selected strains of MDR P.
aeruginosa that confer a highly adhesive and virulent pheno-
type against cultured intestinal epithelial cells. Further
characterization of these appendages and better under-
standing of their molecular regulation are needed to fully
deﬁne their role in the virulence of multi-drug resistant P.
aeruginosa. The observation that critical virulence factors such
as PstS in P. aeruginosa are highly responsive to environmental
phosphate, in conjunction with the observation that intesti-
nal phosphate repletion completely prevented mortality in
surgically injured mice exposed to MDR strains, underscores
the importance of recognizing intestinal phosphate depletion
following catabolic stress and a possible strategy of intestinal
phosphate loading as a countermeasure against colonizing
strains of P. aeruginosa that are resistant to all conventional
antibiotics.
Materials and Methods
Bacterial isolates. The consecutively collected clinical strains of
MDR P. aeruginosa used in the present study (Table 1) have been
characterized and described previously [2]. P. aeruginosa strains
MPAO1, MPAO1 mutant DPA5369 (PA5369:: ISphoA/hah, ID 29772,
and MPAO1 mutant DPA0686 (PA0686:: ISphoA/hah, ID 957) were
obtained from the P. aeruginosa mutant library [13]. The mutant
DPA5369 was complemented with pa5369 gene to create strain
DPA5369/ pa5369, and the mutant DPA0686 was complemented with
DNA comprising pa0686 plus pa0687 genes to create the strain
DPA0686/ pa0686-pa0687. The MDR clinical isolates were routinely
subcultured from frozen stocks on Pseudomonas isolation agar (PIA)
containing Gm, 50 lg/ml. Note that strain 25, herein referred to as
MDR25, and all strains of genotype 20 (see Table 1) did not grow on
rich media (LB- liquid or agarized) or TSB (liquid or agarized), and
did not grow in the specially designed phosphate limited liquid media
described by Hancock [58]. We observed strain MDR25 growth was
best supported in Pseudomonas broth that we determined to contain 2
mM Pi, and PIA determined to contain ;0.3 mM Pi.
Assessment of barrier function of cultured human intestinal
epithelial cells. Human intestinal epithelial cells Caco-2bbe were
grown to conﬂuence in 0.3 cm
2 transwells (Costar), and their barrier
function was assessed by measuring the transepithelial electrical
resistance (TER) to a ﬁxed current across cells as previously described
[2]. All experiments were performed in triplicate.
Adhesiveness. Adhesiveness of P. aeruginosa to Caco-2 bbe cells was
determined as previously described [2]. All experiments were
performed in triplicate.
Bioﬁlm. Bioﬁlm formation was assayed as described with mod-
iﬁcations [59]. Brieﬂy, P. aeruginosa MDR clinical strains were grown
overnight in 2 ml of PB, Gm 50 lg/ml in 15 ml culture tubes at 378C,
200 rpm (C24 Incubator Shaker, New Brunswick Scientiﬁc, Edison,
NJ). The wells were then rinsed thoroughly with water and the
attached material was stained with 3 ml of 0.1% crystal violet, washed
with water, and solubilized in 3 ml of ethanol. Solubilized fractions
were collected and absorbance measured at 550 nm. All experiments
were performed in triplicate.
Identiﬁcation of protein on novel surface structures. P. aeruginosa
strains were grown on PIA plate, than bacteria were harvested,
suspended in PBS, and surface-associated structures were sheared by
vigorous vortexing for 2 min. After centrifuging at 5,000g, for 5 min,
proteins in the supernatant were separated using 10% Tris-glycine
SDS-polyacrylamide gel and detected by Coomassie brilliant blue
staining. For amino-terminal peptide sequence analysis, the proteins
were electroblotted onto polyvinylidene ﬂuoride (PVDF) membranes,
and sequenced by Edman degradation chemistry using an Applied
Biosystems Procise 492 HT Protein Sequencer (Applied Biosystems,
Foster City, CA) at the Mayo Proteomics Research Center (Mayo
Clinic College of Medicine, Rochester, MN).
Antibodies and immunoblot analysis. Polyclonal rabbit antiserum
against 192–212 peptide KEEALCKGDFRPNVNEQPGS of PA5369
(anti-PA5369) was produced in rabbits (SynPep Corporation, Dublin,
CA). Anti- PA5369 antibodies were afﬁnity puriﬁed by AminoLink
Plus Immobilization Kit (Pierce) using 192–212 peptide to create an
afﬁnity column. For immunoblot analysis, proteins were electro-
transferred from SDS-polyacrylamide gels to PVDF membrane
(Immobilon-P, Millipore) and primed with afﬁnity pure anti-
PA5369 antibodies at 1:1,000 dilution. Afﬁnity pure F(ab)2 fragments
of anti-rabbit IgG conjugated with horseradish peroxidase (Jackson
Immunological Res Lab) at 1:5,000 dilution was used as secondary
antibody. Detection was performed using SuperSignal West Dura
Extended Duration Substrate (Pierce).
Enzyme-linked immunosorbent assay (ELISA). P. aeruginosa strains
were grown on PIA plates for 2 days, bacteria were harvested,
suspended in PBS containing protease inhibitor cocktail (Roche) to
create a cell density of 5.0 (OD 600 nm) in a total volume of 500 ll,
and centrifuged at 6,000 rpm, 5 min. The pellet was resuspended in
500 ll PBS containing protease inhibitor cocktail, and vigorously
vortexed for 2 min. Cell surface associated proteins were separated by
centrifuging for 5 min at 5,000 g. After centrifugation, the super-
natants were diluted (1:5) with carbonate-bicarbonate buffer (Sigma),
and 200 ll/well was used for coating Maxisorp Loose Immuno-
modules (Nunc). Plates were incubated at 48C, overnight, washed with
PBS, and unbound sites were blocked with 3% bovine serum albumin
in PBS for 30 min at room temperature. Rabbit polyclonal afﬁnity
puriﬁed anti-5369 antibody (1:1,000) followed by HRP-labeled afﬁnity
puriﬁed F(ab)2 fragments of anti-Rb IgG (Jackson Immunological
Research Laboratories) (1:5,000), and o-phenylaminediamine (Sigma)
were used to detect PA5369-like protein at 450 nm optical density.
Puriﬁcation of Fab fragment of anti-PA5369 antibodies. Polyclonal
afﬁnity puriﬁed rabbit anti-PA5369 antibody against 192–212 peptide
of PA5369 were used to isolate Fab fragment by ImmunoPure Fab
Preparation Kit (Pierce) accordingly to manufacturer protocol.
Electron and immuno-electron microscopy. Transmission electron
microscopic analysis was performed as previously described [60] with
minor modiﬁcations. Brieﬂy, bacteria were grown for 48 hours on
PIA media with/without Gm, 20 lg/ml. A drop of water was deposited
on the edge of colony, and a Formvar-coated copper grid was
immediately ﬂoated on the drop for 30 s, then rinsed with TE buffer
(10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and stained with a 1%
aqueous solution of uranyl acetate. Samples were examined under
300 KV with a FEI Tecnai F30 electron microscope.
For immuno-gold labeling, 200 mesh formvar-coated nickel grids
were rinsed with TE buffer, rehydrated with PBS for 30 min and
blocked with 1% BSA for 30 min followed by transferring to anti-
PA5369 antibodies diluted as 1:100 in 1% BSA. Incubation was
allowed at a humidiﬁed chamber for 3.5 hours, at room temperature,
followed by extensive washing with PBS, blocking with 0.1% BSA for
25 min, and incubating in the humidiﬁed chamber for 1 hour with
goat anti-rabbit IgG conjugated with 10 nm gold particles (TED
PELLA) at 1:10 dilution in 0.1% BSA. Grids were washed with PBS,
ﬁxed with 1% glutaraldehyde in PBS for 10 min, washed with water,
and stained brieﬂy with uranyl acetate and lead citrate. Air dried
grids were examined under 300KV with FEI Tecnai F30.
Construction of pUCP24/5369. The pa5369 gene was ampliﬁed
using PAO1 DNA and primers forward 5369F EcoRI 5’ CCGGAATTC-
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GACAAGTCACTGGATTACAG 3’ and cloned in E.coli-P. aeruginosa
shuttle vector pUCP24 [61] using EcoRI and XbaI restriction sites to
create pUCP24/5369 where pa5369 is expressed from Plac promoter.
The plasmid pUCP24/5369 was electroporated in DPA5369 to create
strain D5369/5369.
Construction of pUCP24/0686–0687. The DNA containing pa0686
and pa0687 was ampliﬁed using PAO1 DNA and primers forward
PA0686-744301F-EcoRI 5’ CCGGAATTCGCGCGGTACCGTTGG 3’
and PA0687-746961R-XbaI 5’ GCTCTAGACGGACTACTGGAC-
CAGTTG 3’and cloned in E.coli-P. aeruginosa shuttle vector pUCP24
[61] using EcoRI and XbaI restriction sites to create pUCP24/0686–
0687 under regulation of Plac promoter. The plasmid pUCP24/0686–
0687 was electroporated in the MPAO1 mutant strain DHxcR
(DPA0686) to create strain DHxcR/0686–0687.
Ampliﬁcation and sequencing of genes analogous to pstS in MDR
clinical isolates of P. aeruginosa. The forward primer 5369F EcoRI 5’
CCGGAATTCGATGAAACTCAAGCGTTTG 3’and reverse primer
5369R XbaI 5’ GCTCTAGACAAGTCACTGGATTACAG 3’ were
designed based on the sequence of P. aeruginosa PAO1 genome and
used to amplify genes using genome DNA isolated from strains MDR
1, MDR 13, and MDR 25. The gene analogous to pa14–55410 was
ampliﬁed using genome DNA of strain MDR1, and primers 55410F
EcoRI 5’CCGGAATTCGATGTACAAGCGCTCTCTGAT 3’ and
55410R XbaI 5’ GCTCTAGACAAG TTAGAGCGGACGGCCGAT 3’
designed based on the sequence of P. aeruginosa PA14 genome.
Ampliﬁed DNAs were cloned directly into pCR2.1 (Invitrogen), and
the sequence was obtained using standard M13 Forward and M13
Reverse primers on an Applied Biosystems 3730XL genetic analyzer
(University of Chicago, Cancer Research Center, DNA Sequencing &
Genotyping Facility).
Real-time PCR. Strains MPAO1, MDR25R, MDR25S, and MDR1 were
grown overnight on PIA and PIA supplemented with 10 mM K-Ph
b u f f e r ,p H7 . 0 ,a n dc o l l e c t e dd i r e ctly in the RNA protect buffer
(Qiagen), and RNA isolation, DNA degradation, and cDNA synthesis
were performed as previously described [27]. Real time PCR was
performed on the ABI 7900HT System using SYBR Green qPCR
SuperMix-UDG (Invitrogen), cDNA, and respective primers: for citrate
synthase PA1580 gene gltA, PA1580–434 5’ TCTACCACGACTCCCTG-
GAC 3’ and PA1580–590 5’ TTTTCCGCGTAGTTCAGGTC 3’; for PstS
PA5369 gene pstS, PA5369–148 5’ ACTCTGGCCAACCTGATGAC 3’ and
PA5369–335 5’CCGTACTTCTGCTCGAAAGC 3’; for phosphate uptake
regulator PhoU PA5365 gene phoU, PA5365–523 5’ CGCGAACTGGT-
CACCTACAT 3’ and PA5365–711 5’ CTCGACCTCTTCCTTCATGC 3’;
for low phosphate response regulator PhoB PA5360 gene phoB, PA5360–
7 5’ GGCAAGACAATCCTCATCGT 3’ and PA5360–164 5’CAGTCGAG-
CAGGATCAGGTC 3’; for PstS PA0688 gene pa0688, PA0688–693
5’GGTGAACATCAACAGCAACG 3’ and PA0688–872 5’TAACCGAC-
GATGGAGTAGCC 3’; for PstS analogous to PA14–55410) gene dinG,
S1-DING-427 5’ CTCTGCCGTTCAACAAGTCA 3’ and S1-DING-604
5’CGGGTGAACAGTTCGGTAGT 3’, for HxcX atypical pseudopilin
PA0682 gene hxcX , PA0682–299 5’ AAGACGAGCAGGGCAAGTT 3’and
PA0682–454 5’GTGCATAGGAGGCGAGTACC 3’. 0.5 lgo fR N Aa f t e r
DNAse treatment was converted to cDNA in 20 ll of reaction mixture
(High Capacity cDNA Reverse Transcription kit, Applied Biosystems).
The cDNA and RNA (-RT control) were diluted either as 1:50 (for cS,
pstS 5369, phoU, phoB)o r1 : 1 0( f o rhxcX)o r1 : 5 0 0( f o rpa0688 and dinG),
and 5 ll of diluted mixture was used as a template added to 7.5 llo f
master mix containing as manufactured (Invitrogen) SYBR green, ROX,
and respective primers. The ampliﬁcation was run in 384 well plates.
Expression levels were calculated based on differences in Ct levels.
All primers were conﬁrmed for DNA ampliﬁcation using genome
DNAs from MPAO1 and MDR clinical isolates prior the Real Time
experiments.
Mouse model of lethal gut-derived sepsis. All experiments were
approved by the Animal Care and Use Committee at the University of
Chicago (Protocol IACUC 71744). Six-seven week old male C57BL6
mice were ordered from Harlan Spraque Dawley Animal facility and
allowed at least four days for housing acclimation prior to experi-
ments. The mouse model of gut-derived sepsis was performed as
previously described [15] with following modiﬁcations. Mice drank
either water (no phosphate supplementation), or 0.2x PBS (2 mM Pi),
or 1x PBS (10 mM Pi ) for 36 hours prior to lethality experiments.
Animals were anesthetized (ketamine 100 mg/kg, xylazine 10 mg/kg)
intraperitoneally and a 30% hepatectomy was performed on the left
lobe of the liver, and the bacterial suspension of P. aeruginosa clinical
isolates MDR25 or MDR1 were injected directly into the distal ileum
and cecum with a ﬁne high gauze needle. The abdomen was closed in
two layers with suture, and mice were allowed to drink either water or
PBS but were given no food for 48 hours. Animals were followed for
mortality and sacriﬁced when they appeared septic and moribund.
Mouse lethality studies using rough and smooth colony variants.
Eight-week-old male C57BL6 mice were given only water for 36 hours
prior to hepatectomy. P. aeruginosa MDR25S and MDR25R were
grown overnight in Pseudomonas broth (PB) containing Gm, 50 lg/ml.
Overnight cultures were diluted as 1:500–1:250 in water containing
10% glycerol, and 20–50 ll were plated on PIA, Gm, 50 lg/ml. After
24–36 hours of growth, cells were collected directly from plates using
an Olympus SZX16 stereo microscope to insure proper collection of
rough and smooth colonies. The cells were diluted in water
containing 10% glycerol to OD600 nm 0.25, and 200 ll of bacterial
suspension was injected in the cecum of mice immediately after
hepatectomy. The abdomen was closed, and mice were allowed
drinking water. Mice were followed for mortality and sacriﬁced when
they appeared septic and moribund. Data were analyzed using
Kaplan-Meier surviving curves and SPSS software employing the
Long-rank (Mantel-Cox) test for signiﬁcance.
Statistical analysis. Statistical analysis of the data was performed
with Student t-test using Sigma plot software and Kaplan-Meier
survival curves using SPSS software.
Supporting Information
Figure S1. TEM Images of MDR and Non-MDR P. aeruginosa
Images of MDR clinical isolates from Table 1 not included in the
main body of paper plus non-MDR control P. aeruginosa strains (2) are
presented in Figure. Bacterial cells grown on Pseudomonas isolation
agar were processed for electron microscopy as described in
Materials and Methods.
(A) Highly virulent MDR clinical isolates: MDR27 and MDR28.
(B) Non-MDR control strains: MPAO1, PA27853, PA190 environ-
mental isolate, and PA103.
Novel appendage-like structures and their detached fragments are
indicated by black arrows, type IV pili are indicated by white arrows,
and ﬂagella are indicated by grey arrows. Note the hyperpiliation of
PA103.
Found at doi:10.1371/journal.ppat.0040043.sg001 (9.8 MB TIF).
Figure S2. TEM Images of MDR P. aeruginosa
Low and non-virulent MDR clinical isolates: MDR2, MDR6, MDR7,
MDR11, MDR15, MDR16, MDR17, MDR19, MDR31, MDR33.
Found at doi:10.1371/journal.ppat.0040043.sg002 (9.7 MB TIF).
Figure S3. TEM and Immuno-Electron Microscopy Images of MDR25
(A) TEM images displaying detached structures of appendages shown
by arrows.
(B) Immuno-electron microscopy with gold-labeled secondary anti-
body identifying PstS indicated by black arrows. Flagella are
indicated by grey arrows. Note lack of antibody afﬁnity to ﬂagella.
Found at doi:10.1371/journal.ppat.0040043.sg003 (8.1 MB TIF).
Figure S4. Growth Curves of MDR25S and MDR25R in Pseudomonas
BrothFigure 1
Found at doi:10.1371/journal.ppat.0040043.sg004 (933 KB TIF).
Accession Numbers
PstS PA5369 (Pseudomonas aeruginosa PAO1), NP_254056; PA0688,
probablebindingproteincomponentofABCtransporter(Pseudomonas
aeruginosa PAO1), NP_249379; PA14_55410, Hypothetical, unclassi-
ﬁed, unknown (Pseudomonas aeruginosa UCBPP-PA14), complete ge-
nome NC_008463; PhoB, two-component response regulator
(Pseudomonas aeruginosa PAO1), NP_254047; HxcX, atypical pseudo-
pilin (Pseudomonas aeruginosa PAO1), NP_249373; PA0686, probable
type II secretion system protein (Pseudomonas aeruginosa PAO1),
complete genome NC_002516; PhoU, phosphate uptake regulatory
protein (Pseudomonas aeruginosa PAO1), NP_254052; citrate synthase
(Pseudomonas aeruginosa PAO1), NP_250271; Pseudomonas aeruginosa
PAO1, complete genome, NC_002516; ExoU (Pseudomonas aeruginosa),
AAC16023; human plasma phosphate-binding protein (HPBP),
P85173.
In the present study: PstS (Pseudomonas aeruginosa MDR1),
EF601157; PstS (Pseudomonas aeruginosa MDR13), EF601158; PstS
(Pseudomonas aeruginosa MDR25), EF601159; DING (Pseudomonas aeru-
ginosa MDR1), EF616488.
PLoS Pathogens | www.plospathogens.org February 2008 | Volume 4 | Issue 2 | e43 0012
PstS-Containing Appendages on MDR P. aeruginosaAcknowledgments
We wish to thank Olga Shevchenko for technical assistance; we are
grateful to Drs. A. Osterman and D. Rodionov who helped us in using
the SEED database and tools (http://theseed.uchicago.edu/FIG/index.
cgi) for comparative genome analysis. We also thank Dr. Robert
Hancock for helpful conversations and his critique of this work.
Author contributions. OZ originated the project, designed all
experiments, did the main work, and wrote the paper; CH performed
mice experiments. YC helped to create electron microscopy images.
JL helped in mice experiments. AZ helped in the RT-PCR experi-
ments. IM made technical contributions throughout the work. HF
helped in the veriﬁcation of mutants. YW made technical contribu-
tions in growing Caco-2 cells. JRT made intellectual contributions
and provided reagents. JCA originated the project, participated in
the experimental design, wrote the paper, and provided grant
support.
Funding. This work was supported by National Institutes of Health
grant RO1 GM62344–05.
Competing interests. The authors have declared that no competing
interests exist.
References
1. Tassios PT, Gennimata V, Spaliara-Kalogeropoulou L, Kairis D, Koutsia C,
et al. (1997) Multiresistant Pseudomonas aeruginosa serogroup O:11 outbreak
in an intensive care unit. Clin Microbiol Infect 3: 621–628.
2. Zaborina O, Kohler JE, Wang Y, Bethel C, Shevchenko O, et al. (2006)
Identiﬁcation of multi-drug resistant Pseudomonas aeruginosa clinical isolates
that are highly disruptive to the intestinal epithelial barrier. Ann Clin
Microbiol Antimicrob 5: 14.
3. Bertrand X, Thouverez M, Talon D, Boillot A, Capellier G, et al. (2001)
Endemicity, molecular diversity and colonisation routes of Pseudomonas
aeruginosa in intensive care units. Intensive Care Med 27: 1263–1268.
4. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, et al.
(1997) ExoU expression by Pseudomonas aeruginosa correlates with acute
cytotoxicity and epithelial injury. Mol Microbiol 25: 547–557.
5. Kang PJ, Hauser AR, Apodaca G, Fleiszig SM, Wiener-Kronish J, et al. (1997)
Identiﬁcation of Pseudomonas aeruginosa genes required for epithelial cell
injury. Mol Microbiol 24: 1249–1262.
6. Lewenza S, Gardy JL, Brinkman FS, Hancock RE (2005) Genome-wide
identiﬁcation of Pseudomonas aeruginosa exported proteins using a consensus
computational strategy combined with a laboratory-based PhoA fusion
screen. Genome Res 15: 321–329.
7. He J, Baldini RL, Deziel E, Saucier M, Zhang Q, et al. (2004) The broad host
range pathogen Pseudomonas aeruginosa strain PA14 carries two pathoge-
nicity islands harboring plant and animal virulence genes. Proc Natl Acad
Sci U S A 101: 2530–2535.
8. Lewenza S, Falsaﬁ RK, Winsor G, Gooderham WJ, McPhee JB, et al. (2005)
Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas
aeruginosa PAO1: A tool for identifying differentially regulated genes.
Genome Res 15: 583–589.
9. Madhusudhan KT, McLaughlin R, Komori N, Matsumoto H (2003)
Identiﬁcation of a major protein upon phosphate starvation of Pseudomonas
aeruginosa PAO1. J Basic Microbiol 43: 36–46.
10. Nikata T, Sakai Y, Shibat K, Kato J, Kuroda A, et al. (1996) Molecular
analysis of the phosphate-speciﬁc transport (pst) operon of Pseudomonas
aeruginosa. Mol Gen Genet 250: 692–698.
11. Poole K, Hancock RE (1986) Phosphate-starvation-induced outer mem-
brane proteins of members of the families Enterobacteriaceae and
Pseudomonodaceae: Demonstration of immunological cross-reactivity with
an antiserum speciﬁc for porin protein P of Pseudomonas aeruginosa.J
Bacteriol 165: 987–993.
12. Jensen V, Lons D, Zaoui C, Bredenbruch F, Meissner A, et al. (2006) RhlR
expression in Pseudomonas aeruginosa is modulated by the Pseudomonas
quinolone signal via PhoB-dependent and -independent pathways. J
Bacteriol 188: 8601–8606.
13. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, et al. (2003)
Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc
Natl Acad Sci U S A 100: 14339–14344.
14. Wu L, Zaborina O, Zaborin A, Chang EB, Musch M, et al. (2004) High-
molecular-weight polyethylene glycol prevents lethal sepsis due to
intestinal Pseudomonas aeruginosa. Gastroenterology 126: 488–498.
15. Laughlin RS, Musch MW, Hollbrook CJ, Rocha FM, Chang EB, et al. (2000)
The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut-
derived sepsis. Ann Surg 232: 133–142.
16. Datta HK, Malik M, Neely RD (2007) Hepatic surgery-related hypophos-
phatemia. Clin Chim Acta 380: 13–23.
17. Ball G, Durand E, Lazdunski A, Filloux A (2002) A novel type II secretion
system in Pseudomonas aeruginosa. Mol Microbiol 43: 475–485.
18. Morales R, Berna A, Carpentier P, Contreras-Martel C, Renault F, et al.
(2007) [Discovery and crystallographic structure of human apolipoprotein].
Ann Pharm Fr 65: 98–107.
19. Berna A, Bernier F, Scott K, Stuhlmuller B (2002) Ring up the curtain on
DING proteins. FEBS Lett 524: 6–10.
20. Berna A, Bernier F, Chabriere E, Perera T, Scott K (2008) DING proteins;
novel members of a prokaryotic phosphate-binding protein superfamily
which extends into the eukaryotic kingdom. Int J Biochem Cell Biol 40:
170–175.
21. Alonso A, Campanario E, Martinez JL (1999) Emergence of multidrug-
resistant mutants is increased under antibiotic selective pressure in
Pseudomonas aeruginosa. Microbiology 145: 2857–2862.
22. Boldin B, Bonten MJ, Diekmann O (2007) Relative effects of barrier
precautions and topical antibiotics on nosocomial bacterial transmission:
Results of multi-compartment models. Bull Math Biol 69: 2227–2248.
23. Pena C, Guzman A, Suarez C, Dominguez MA, Tubau F, et al. (2007) Effects
of carbapenem exposure on the risk for digestive tract carriage of intensive
care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in
critically ill patients. Antimicrob Agents Chemother 51: 1967–1971.
24. Donskey CJ (2006) Antibiotic regimens and intestinal colonization with
antibiotic-resistant gram-negative bacilli. Clin Infect Dis 43: S62–S69.
25. Wu L, Estrada O, Zaborina O, Bains M, Shen L, et al. (2005) Recognition of
host immune activation by Pseudomonas aeruginosa. Science 309: 774–777.
26. Patel NJ, Zaborina O, Wu L, Wang Y, Wolfgeher DJ, et al. (2007)
Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas
aeruginosa. Am J Physiol Gastrointest Liver Physiol 292: G134–G142.
27. Zaborina O, Lepine F, Xiao G, Valuckaite V, Chen Y, et al. (2007)
Dynorphin activates quorum sensing quinolone signaling in Pseudomonas
aeruginosa. LoS Pathog 3: e35. doi:10.1371/journal.ppat.0030035
28. Wu LR, Zaborina O, Zaborin A, Chang EB, Musch M, et al. (2005) Surgical
injury and metabolic stress enhance the virulence of the human
opportunistic pathogen Pseudomonas aeruginosa. Surg Infect (Larchmt) 6:
185–195.
29. Kohler JE, Zaborina O, Wu L, Wang Y, Bethel C, et al. (2005) Components
of intestinal epithelial hypoxia activate the virulence circuitry of
Pseudomonas. Am J Physiol Gastrointest Liver Physiol 288: G1048–G1054.
30. de Menezes FS, Leite HP, Fernandez J, Benzecry SG, de Carvalho WB (2006)
Hypophosphatemia in children hospitalized within an intensive care unit. J
Intensive Care Med 21: 235–239.
31. Giovannini I, Chiarla C, Nuzzo G (2002) Pathophysiologic and clinical
correlates of hypophosphatemia and the relationship with sepsis
and outcome in postoperative patients after hepatectomy. Shock 18: 111–
115.
32. Miller DW, Slovis CM (2000) Hypophosphatemia in the emergency
department therapeutics. Am J Emerg Med 18: 457–461.
33. Cohen J, Kogan A, Sahar G, Lev S, Vidne B, et al. (2004) Hypophosphatemia
following open heart surgery: Incidence and consequences. Eur J
Cardiothorac Surg 26: 306–310.
34. Grunberg W, Morin DE, Drackley JK, Barger AM, Constable PD (2006)
Effect of continuous intravenous administration of a 50% dextrose
solution on phosphorus homeostasis in dairy cows. J Am Vet Med Assoc
229: 413–420.
35. Bohannon NJ (1989) Large phosphate shifts with treatment for hyper-
glycemia. Arch Intern Med 149: 1423–1425.
36. Martinez MJ, Martinez MA, Montero M, Campelo E, Castro I, et al. (2006)
Hypophosphatemia in postoperative patients with total parenteral
nutrition: inﬂuence of nutritional support teams. Nutr Hosp 21: 657–
660.
37. Llop Talaveron JM, Comas Sugranes D, Badia Tahull MB, Saez Fernandez A,
Jodar Masanes R, et al. (2004) [Hypophosphatemia in parenteral nutrition:
Prevention and associated risks factors]. Nutr Hosp 19: 362–366.
38. Shor R, Halabe A, Rishver S, Tilis Y, Matas Z, et al. (2006) Severe
hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 36:
67–72.
39. Cresci G, Cue JI (2006) Nutrition support for the long-term ventilator-
dependent patient. Respir Care Clin N Am 12: 567–591, vi.
40. Diaz M, Esteban A, Fernandez-Abalos JM, Santamaria RI (2005) The high-
afﬁnity phosphate-binding protein PstS is accumulated under high fructose
concentrations and mutation of the corresponding gene affects differ-
entiation in Streptomyces lividans. Microbiology 151: 2583–2592.
41. Lewis AP, Crowther D (2005) DING proteins are from Pseudomonas. FEMS
Microbiol Lett 252: 215–222.
42. Scott K, Wu L (2005) Functional properties of a recombinant bacterial
DING protein: Comparison with a homologous human protein. Biochim
Biophys Acta 1744: 234–244.
43. Morales R, Berna A, Carpentier P, Contreras-Martel C, Renault F, et al.
(2006) Serendipitous discovery and X-ray structure of a human phosphate
binding apolipoprotein. Structure 14: 601–609.
44. Baek JH, Lee SY (2006) Novel gene members in the Pho regulon of
Escherichia coli. FEMS Microbiol Lett 264: 104–109.
45. Monds RD, Newell PD, Schwartzman JA, O’Toole GA (2006) Conservation
of the Pho regulon in Pseudomonas ﬂuorescens Pf0–1. Appl Environ Microbiol
72: 1910–1924.
PLoS Pathogens | www.plospathogens.org February 2008 | Volume 4 | Issue 2 | e43 0013
PstS-Containing Appendages on MDR P. aeruginosa46. Hove-Jensen B (1996) Phosphoribosyl diphosphate synthetase-independent
NAD de novo synthesis in Escherichia coli: A new phenotype of phosphate
regulon mutants. J Bacteriol 178: 714–722.
47. Han JS, Park JY, Lee YS, Thony B, Hwang DS (1999) PhoB-dependent
transcriptional activation of the iciA gene during starvation for phosphate
in Escherichia coli. Mol Gen Genet 262: 448–452.
48. Suziedeliene E, Suziedelis K, Garbenciute V, Normark S (1999) The acid-
inducible asr gene in Escherichia coli: transcriptional control by the phoBR
operon. J Bacteriol 181: 2084–2093.
49. Ruiz N, Silhavy TJ (2003) Constitutive activation of the Escherichia coli Pho
regulon upregulates rpoS translation in an Hfq-dependent fashion. J
Bacteriol 185: 5984–5992.
50. Zhang Y, Cottet SE, Ealick SE (2004) Structure of Escherichia coli AMP
nucleosidase reveals similarity to nucleoside phosphorylases. Structure 12:
1383–1394.
51. Soualhine H, Brochu V, Menard F, Papadopoulou B, Weiss K, et al. (2005) A
proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals
a novel role for PstS, a subunit of the phosphate ABC transporter. Mol
Microbiol 58: 1430–1440.
52. Bhatt K, Banerjee SK, Chakraborti PK (2000) Evidence that phosphate
speciﬁc transporter is ampliﬁed in a ﬂuoroquinolone resistant Mycobacte-
rium smegmatis. Eur J Biochem 267: 4028–4032.
53. Banerjee SK, Bhatt K, Misra P, Chakraborti PK (2000) Involvement of a
natural transport system in the process of efﬂux-mediated drug resistance
in Mycobacterium smegmatis. Mol Gen Genet 262: 949–956.
54. Chakraborti PK, Bhatt K, Banerjee SK, Misra P (1999) Role of an ABC
importer in mycobacterial drug resistance. Biosci Rep 19: 293–300.
55. Peirs P, Lefevre P, Boarbi S, Wang XM, Denis O, et al. (2005)
Mycobacterium tuberculosis with disruption in genes encoding the
phosphate binding proteins PstS1 and PstS2 is deﬁcient in phosphate
uptake and demonstrates reduced in vivo virulence. Infect Immun 73:
1898–1902.
56. Srinivasa Rao PS, Lim TM, Leung KY (2003) Functional genomics approach
to the identiﬁcation of virulence genes involved in Edwardsiella tarda
pathogenesis. Infect Immun 71: 1343–1351.
57. Lamarche MG, Dozois CM, Daigle F, Caza M, Curtiss R 3rd, et al. (2005)
Inactivation of the pst system reduces the virulence of an avian pathogenic
Escherichia coli O78 strain. Infect Immun 73: 4138–4145.
58. Hancock RE, Rafﬂe VJ, Nicas TI (1981) Involvement of the outer membrane
in gentamicin and streptomycin uptake and killing in Pseudomonas
aeruginosa. Antimicrob Agents Chemother 19: 777–785.
59. O’Toole GA, Kolter R (1998) Initiation of bioﬁlm formation in Pseudomonas
ﬂuorescens WCS365 proceeds via multiple, convergent signalling pathways: A
genetic analysis. Mol Microbiol 28: 449–461.
60. Haussler S, Ziegler I, Lottel A, von Gotz F, Rohde M, et al. (2003) Highly
adherent small-colony variants of Pseudomonas aeruginosa in cystic ﬁbrosis
lung infection. J Med Microbiol 52: 295–301.
61. West SE, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ (1994)
Construction of improved Escherichia-Pseudomonas shuttle vectors derived
from pUC18/19 and sequence of the region required for their replication
in Pseudomonas aeruginosa. Gene 148: 81–86.
PLoS Pathogens | www.plospathogens.org February 2008 | Volume 4 | Issue 2 | e43 0014
PstS-Containing Appendages on MDR P. aeruginosa